PFE
Pfizer Inc.
Price performance
Sep 18, 2026About
Company activity
27 events| Time | Ticker | Type | Event | Qty | Price | Value |
|---|---|---|---|---|---|---|
| 08/04 | PFE | 8-K | Pfizer Announces Second Quarter 2026 Financial Results | — | — | — |
| 06/18 | PFE | 8-K | Pfizer Reaffirms Fiscal Year 2026 Guidance | — | — | — |
| 06/18 | PFE | 8-K | Pfizer Announces CFO Transition | — | — | — |
| 05/05 | PFE | 8-K | Pfizer Announces First Quarter 2026 Financial Results | — | — | — |
| 04/27 | PFE | 8-K | Pfizer Inc. Announces Election Results from Annual Meeting of Shareholders | — | — | — |
| 02/03 | PFE | 8-K | Pfizer Announces Fourth Quarter 2025 Financial Results | — | — | — |
| 12/16/25 | PFE | 8-K | Pfizer Provides Full-Year 2026 Guidance and Revises 2025 Revenue Forecast | — | — | — |
| 11/21/25 | PFE | 8-K | Pfizer Inc. Completes Public Offering of Various Notes | — | — | — |
| 11/13/25 | PFE | 8-K | Pfizer Completes Acquisition of Metsera, Inc. | — | — | — |
| 11/04/25 | PFE | 8-K | Pfizer Announces Third Quarter 2025 Financial Results | — | — | — |
| 08/05/25 | PFE | 8-K | Pfizer Announces Second Quarter 2025 Financial Results | — | — | — |
| 05/19/25 | PFE | 8-K | Pfizer Inc. Subsidiary Completes €3.3 Billion Debt Offering | — | — | — |
| 04/29/25 | PFE | 8-K | Pfizer Announces First Quarter 2025 Financial Results and Expanded Cost Realignment Program | — | — | — |
| 04/28/25 | PFE | 8-K | Pfizer Inc. Announces Results of Annual Meeting of Shareholders | — | — | — |
| 02/04/25 | PFE | 8-K | Pfizer Announces 2024 Full-Year and Fourth-Quarter Financial Results | — | — | — |
| 12/17/24 | PFE | 8-K | Pfizer Provides Full-Year 2025 Guidance and Reaffirms 2024 Guidance | — | — | — |
| 10/29/24 | PFE | 8-K | Pfizer Inc. Announces Third Quarter 2024 Financial Results | — | — | — |
| 10/15/24 | PFE | 8-K | Pfizer Inc. Elects Tim Buckley to Board of Directors | — | — | — |
| 07/30/24 | PFE | 8-K | Pfizer Reports Second Quarter 2024 Financial Results | — | — | — |
| 07/26/24 | PFE | 8-K | Pfizer Extends Long-Term Incentive Grants for Employee Retention | — | — | — |
| 07/10/24 | PFE | 8-K | Pfizer Announces Beginning of Search for New Chief Scientific Officer | — | — | — |
| 07/01/24 | PFE | 8-K | Pfizer Appoints Cyrus Taraporevala to Board of Directors | — | — | — |
| 05/22/24 | PFE | 8-K | Pfizer Announces Multi-Year Cost Reduction Program | — | — | — |
| 05/01/24 | PFE | 8-K | Pfizer Announces First Quarter 2024 Financial Results | — | — | — |
| 04/29/24 | PFE | 8-K | Pfizer Annual Meeting Voting Results | — | — | — |
| 01/30/24 | PFE | 8-K | Pfizer Announces Fourth-Quarter and Full-Year 2023 Financial Results | — | — | — |
| 01/10/24 | PFE | 8-K | Pfizer Issues Warning Against TRC Capital's Below-Market Mini-Tender Offer | — | — | — |
PFE filing record
Pfizer Inc. (PFE): 27 8-K filings summarized, the most recent on Aug 4, 2026.
What the 8-K filings said
- Aug 4, 2026 · low impact
On August 4, 2026, Pfizer Inc. announced its financial results for the second quarter of 2026. The results were reported in a press release furnished as Exhibit 99 to this 8-K filing. This announcement provides investors with an update on Pfizer's financial performance for the quarter.
Pfizer Announces Second Quarter 2026 Financial Results - Jun 18, 2026 · low impact
Pfizer Inc. has reaffirmed its fiscal year 2026 guidance, maintaining the previously announced revenue range of $59.5 to $62.5 billion and the Adjusted Diluted EPS range of $2.80 to $3.00. This reaffirmation follows the recent announcement of the transition of the Chief Financial Officer. Further details can be found…
Pfizer Reaffirms Fiscal Year 2026 Guidance - Jun 18, 2026 · high impact
On June 16, 2026, Pfizer Inc. announced that Dave Denton, its Chief Financial Officer, will step down from his position effective August 15, 2026, to pursue a career in the consumer goods industry. Cecile Guegan, currently Senior Vice President, Finance, Global Biopharmaceutical Business, has been appointed as Interim…
Pfizer Announces CFO Transition - May 5, 2026 · low impact
On May 5, 2026, Pfizer Inc. announced its financial results for the first quarter of 2026. The company reported its revenue, earnings per share (EPS), and other key financial metrics. A detailed press release is furnished as Exhibit 99 to this 8-K filing.
Pfizer Announces First Quarter 2026 Financial Results - Apr 27, 2026 · high impact
Pfizer Inc. held its Annual Meeting of Shareholders on April 23, 2026, where shareholders elected the nominees for the Board of Directors, ratified KPMG LLP as the independent registered public accounting firm, approved the Pfizer Inc. 2019 Stock Plan, approved the 2026 compensation of the Named Executive Officers on…
Pfizer Inc. Announces Election Results from Annual Meeting of Shareholders
SEC filings in the last five years
- 49 Form 8-K
- 13 Form 10-Q
- 5 Form 10-K
- 1 Form 8-K/A